Onegene Biotechnology Inc.

[On Demand]
Onegene Biotechnology is a biopharmaceutical company developing microenvironment-targeting protein drugs for non-alcoholic steatohepatitis (NASH), fibrotic diseases and cancers. The company's unique technology platform, UniStac, allows simultaneous targeting of three or more targets, thereby potentially providing transformative opportunities to cure patients suffering from chronic and complex diseases.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
OGB21502 (drug for NASH)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Onegene Biotechnology Inc.